Clinical Trials Logo

Clinical Trial Summary

In the present study the investigators assessed the invitro role of IL-4 and IFN-γ in predicting the response to bivalent HPV vaccine after whole blood stimulation


Clinical Trial Description

40 Patients and 40 controls are enrolled in the study. Participants suffer from chronic recurrent cutaneous and genital warts. Blood samples were withdrawn then whole blood cultures are prepared. Cultures are stimulated with bivalent HPVvaccine. IL-4 and IFN-γ measurement in culture supernatants by ELISA. IL-4 and IFN-γ are investigated to predict the therapeutic response to bivalent HPV vaccine immunotherapy in warts. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05100043
Study type Observational
Source Zagazig University
Contact
Status Completed
Phase
Start date January 3, 2020
Completion date March 2, 2021

See also
  Status Clinical Trial Phase
Completed NCT03487549 - Cantharidin and Occlusion in Verruca Epithelium Phase 2
Completed NCT04554394 - CellFX System for the Treatment of Cutaneous Non-Genital Warts N/A
Completed NCT04738734 - CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts N/A